Savara Inc. (SVRA) - Latest Market Data

Price & Market Data

Price: $3.21

Daily Change: -$0.045 / 1.40%

Range: $3.18 - $3.29

Market Cap: $553,288,704

Volume: 188,800

Performance Metrics

1 Week: 8.87%

1 Month: 15.16%

3 Months: 10.76%

6 Months: -10.64%

1 Year: -32.13%

YTD: 3.91%

Company Details

Employees: 59

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Langhorne, Pennsylvania.

Selected stocks

Phathom Pharmaceuticals, Inc. (PHAT)

Cosan S.A. (CSAN)

Cloudastructure, Inc. (CSAI)